Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trial-Reference-Cited by-同舟云学术

Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trial

Published:2024-11 Issue: Volume:200 Page:110524
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Ma Huiying,Li Haoyue,Xu Tongzhen,Gao Yuanhong,Liu Shixin,Wang Wenling,Wei Lichun,Wang Xishan,Jiang Liming,Chi Yihebali,Shi Jinming,Shuai Jiacheng,Zou Shuangmei,Cai Yong,Zhu Yuan,Cheng Guanghui,Zhang Hongyan,Wang Xin,Zhu Suyu,Wang Jun,Li Gaofeng,Yang Jialin,Zhang Kuan,Lu Ningning,Fang Hui,Wang Shulian,Li Yexiong,Zhou Haitao,Tang Yuan,Jin Jing

Funder

Sanming Project of Medicine in Shenzhen

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference39 articles.

1. Benson AB, VA, Al-Hawary MM et al. NCCN guidelines: Rectal cancer, version; 2023.

2. Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR);Jin;J Clin Oncol,2022

3. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial;Bahadoer;Lancet Oncol,2021

4. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial;Conroy;Lancet Oncol,2021

5. Long-course oxaliplatin-based preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study;Bujko;Ann Oncol: Off J Eur Soc Med Oncol,2016